Anna Svensson

Anna Svensson is an accomplished professional in the biotechnology and healthcare industries, currently serving as a Board Member at Amgen since October 2021. In this role, Anna provides strategic oversight to align the company's long-term vision with its operational priorities and innovation initiatives. Prior to Amgen, Anna spent a decade at Fresenius Medical Care, where responsibilities included serving as a Senior Business Development Executive and overseeing a cross-functional team in healthcare market segments. Earlier experience as a Research and Development Assistant involved contributions to the development of dialysis products. Anna holds a Master of Business Administration in Biomedical Management and Medical Economics from Munich Business School, enhancing expertise in healthcare innovation.